Status:
WITHDRAWN
Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Childhood Atypical Teratoid/Rhabdoid Tumor
Rhabdoid Tumor of the Kidney
Eligibility:
All Genders
Brief Summary
This research trial studies biomarkers in samples from patients with rhabdoid tumor of the kidney and atypical teratoid rhabdoid tumor. Studying biomarkers of tissue samples from patients with cancer ...
Detailed Description
PRIMARY OBJECTIVES: I. To determine if there are molecular differences between rhabdoid tumor of the kidney (RTK) and the atypical teratoid rhabdoid tumor (ATRT). OUTLINE: Archived tumor tissue sam...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Samples of RTK and ATRT provided by the Children?s Oncology Group (COG)
Exclusion
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01453465
Start Date
November 1 2011
Last Update
August 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Oncology Group
Philadelphia, Pennsylvania, United States, 19104